Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 24:17:239-248.
doi: 10.2147/PPA.S387813. eCollection 2023.

Understanding Processes, Outcomes, and Contexts in Medication Adherence: The Medication Adherence Context and Outcomes (MACO) Framework

Affiliations

Understanding Processes, Outcomes, and Contexts in Medication Adherence: The Medication Adherence Context and Outcomes (MACO) Framework

Rebecca J Bartlett Ellis et al. Patient Prefer Adherence. .

Abstract

Poor medication adherence is a significant problem, yet interventions to improve it have been largely ineffective. Existing ecological models indicate that adherence is multi-dimensional; however, they do not reflect understanding of context-specific processes and how they lead to adherence outcomes. A framework that reflects context-specific processes is important because it could be used to inform context-specific intervention delivery and measure associated adherence outcomes. The purpose of this paper is to describe the Medication Adherence Context and Outcomes (MACO) framework, which includes contexts (ie, clinics, pharmacies, and home) and context-specific processes (ie, shared decision-making, prescription filling strategies, home medication management) that lead to adherence outcomes (initiation, implementation, discontinuation, and persistence). The Medication and Adherence Contexts and Outcomes (MACO) framework was iteratively developed between 2015 and 2018 based on theory, practice, and research and combining patient experience journey mapping to chronologically describe the environmental contexts and actions (processes) that occur within the contexts and how they contribute to medication adherence as outcome. The three distinct yet interrelated contexts described in the MACO framework are 1) clinical encounters, 2) pharmacy encounters, and 3) day-to-day home management. Within these contexts are specific medication management actions that occur (processes) in order to produce adherence-related outcomes (initiation, implementation, and discontinuation/persistence). The MACO framework distinguishes context-specific processes and outcomes. The MACO framework may be useful to understand at which point(s) along the continuum people experience problems with managing medications. This understanding is potentially useful for developing and delivering context-specific interventions that are based on processes that underlie nonadherence and selecting adherence measures appropriate for the contexts.

Keywords: ecological models; health behavior; implementation; medication adherence; medication management.

PubMed Disclaimer

Conflict of interest statement

Rebecca J Bartlett Ellis and Todd M Ruppar report unrelated research and consulting support from Beckton Dickinson. Todd M Ruppar also reports personal fees from SAGE Publications, Wolters Kluwer, and The Medicines Company (Novartis) outside the submitted work. Rebecca Bartlett Ellis also reports disclosure of unrelated patented method and system for autonomously measuring, recording, and reporting changes in the interior content of containers (AKA “Smart Pillbox” ; US 10857070). The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
The MACO framework. The medication adherence context and outcomes framework image by Bartlett Ellis RJ and Ruppar TM is licensed under a creative commons international 4.0 license. Available from: https://scholarworks.iupui.edu/handle/1805/30882.

References

    1. New England Health Care Institute. Thinking Outside the Pillbox: A System-Wide Approach to Improving Patient Medication Adherence for Chronic Disease. New England Health Care Institute; 2009.
    1. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008 - DOI - PMC - PubMed
    1. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x - DOI - PMC - PubMed
    1. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–562. doi:10.1007/s40265-013-0041-3 - DOI - PMC - PubMed
    1. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657–665. doi:10.1093/ajhp/60.7.657 - DOI - PubMed